ObsEva Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Amicus Therapeutics.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 2000 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Heidelberg, DE HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 76 | Employees 58415% increase |
Valuation ($) | Valuation ($) 52.5 m | Valuation ($) 3.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit $561.3m (FY, 2025) |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company